Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic Malignancies

BACKGROUND: Proportionate female representation in health research is necessary for scientific rigor and health equity. We aimed to assess the representation of women in clinical trials leading to U.S. Food and Drug Administration (FDA) cancer drug approvals. MATERIALS AND METHODS: Trials supporting...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Mendis, Shehara, Anand, Seerat, Karasinska, Joanna M., Dasari, Arvind, Unger, Joseph M., Gothwal, Anirudh, Ellis, Lee M., Varadhachary, Gauri, Kopetz, Scott, Overman, Michael J., Raghav, Kanwal, Loree, Jonathan M.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2020
Assuntos:
Community Outreach
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7873318/
https://ncbi.nlm.nih.gov/pubmed/32960478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13534
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares